The fact that the FDA head criticized him when this problem was caused by the FDA in the first place might be peak irony. See https://www.cnbc.com/2018/09/12/n

The fact that the FDA head criticized him when this problem was caused by the FDA in the first place might be peak irony. See https://www.cnbc.com/2018/09/12/nostrum-ceo-says-he-wasnt-defending-shkreli-he-was-condemning-fda.html https://www.cnbc.com/2018/09/12/nostrum-ceo-says-he-wasnt-de... >But Mulye disagrees. He said new FDA guidance on elemental impurities in medicines required a reformulation of nitrofurantoin, so Nostrum pulled the product out of the market while it implemented the necessary changes. It plans to re-introduce it "shortly," Mulye said. >"After the regulation came into effect, I don't think anybody manufactured the product," Mulye said. "That's going to create exclusivity in the market. Then the price goes up."